Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HAE | ADPT |
|---|---|---|
| Price | $104.68 | $29.84 |
| Change today | ▲ 0.00% | ▲ 5.26% |
| Market cap | $4.76B | $4.76B |
| Return, 3 months | +39.8% | +43.3% |
| Return, year to date | +30.6% | +83.7% |
| Return, 1 year | +111.3% | +106.2% |
| P/E (TTM) | 50.6 | -74.6 |
| P/B | 5.7 | 33.3 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -2.0% | +21.5% |
| Net profit growth (YoY) | -42.0% | -56.1% |
| Gross margin | 59.0% | 75.6% |
| Operating margin | 18.1% | -12.2% |
| Net margin | 7.1% | -20.7% |
| Return on equity | 11.2% | -39.6% |
| Analyst target vs. price | +11.5% | +2.5% |
| Analyst buy share | 86% | 100% |
| RSI (14) | 54 | 65 |
| 30-day volatility | 17.3% | 46.1% |
| Max drawdown, 1 year | -40.1% | -39.3% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
